I still scratch my head in wonder at ESR's market cap. being 30% more than that of SGQ. Nothing against ESR, but "fair value" for SGQ must surely be at least double the current, if not a treble.
If the current Glycine Leaching testing process can be a cheap way forward to processing our shallow stuff - already known and yet to be discovered, then we must surely be in for one helluva re-rate I reckon!
